ASTRIA THERAPEUTICS
Catabasis Pharmaceuticals is a biopharmaceutical company located in Cambridge, Massachusetts focused on the discovery and development of innovative drugs to treat inflammatory conditions. Their platform technology enables the discovery and development of small molecules that simultaneously and specifically target pathways in the inflammatory response. The Catabasis platform will lead to the development of a novel mechanism of action therapies to safely and effectively treat inflammatory diseases.
ASTRIA THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2008-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.astriatx.com
Total Employee:
11+
Status:
Active
Contact:
(617) 349-1971
Email Addresses:
[email protected]
Total Funding:
656.44 M USD
Technology used in webpage:
SPF IPv6 Microsoft Exchange Online Google Office 365 Mail Microsoft Azure DNS COVID-19 Akamai Hosted Mimecast InMotion Hosting
Similar Organizations
Anthos Therapeutics
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
BTNX
BTNX is a biotech firm that specializes in R&D and the manufacture of advanced in-vitro diagnostic tests and point-of-care diagnostics.
Ceria Therapeutics
Ceria Therapeutics develops innovative and novel therapies to treat overactive and nonproductive inflammation to promote healing.
Idenix Pharmaceuticals
Idenix Pharmaceuticals is focused on the discovery and development of drugs for the treatment of human viral diseases.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Synta Pharmaceuticals
Synta Pharmaceuticals is focused on developing and commercializing small molecule drugs to treat cancer and chronic inflammatory diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-01-29 | Quellis Biosciences | Quellis Biosciences acquired by Astria Therapeutics | N/A |
Investors List
Adage Capital Management
Adage Capital Management investment in Post-IPO Equity - Astria Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Astria Therapeutics
TCG Crossover
TCG Crossover investment in Post-IPO Equity - Astria Therapeutics
Driehaus Capital Management
Driehaus Capital Management investment in Post-IPO Equity - Astria Therapeutics
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Astria Therapeutics
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Post-IPO Equity - Astria Therapeutics
SV Health Investors
SV Health Investors investment in Series B - Astria Therapeutics
Advanced Technology Ventures
Advanced Technology Ventures investment in Series B - Astria Therapeutics
Lightstone Ventures
Lightstone Ventures investment in Series B - Astria Therapeutics
MedImmune Ventures
MedImmune Ventures investment in Series B - Astria Therapeutics
Key Employee Changes
Official Site Inspections
http://www.astriatx.com Semrush global rank: 14.09 M Semrush visits lastest month: 60
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Astria Therapeutics"
About Us - Astria TX
We listen to the communities of those impacted by allergic and immunologic diseases, learn from, and are guided by their experiences, and work to create therapies that treat the disease and improve patient quality of life.See details»
Our Commitment to DE&I - Astria TX
We are working to develop and implement initiatives that promote diversity, equity, and inclusion throughout the organization and foster a culture of openness, respect, and collaboration, where all voices are heard, and …See details»
Astria Therapeutics - Crunchbase Company Profile
Astria Therapeutics discovers and develops innovative drugs for treating inflammatory conditions. Astria Therapeutics reported its first quarter 2024 financial results and provided a corporate update. The company has managed …See details»
Astria Therapeutics, Inc. | LinkedIn
Astria Therapeutics, Inc. | 11,032 followers on LinkedIn. At Astria Therapeutics, our team is focused on bringing therapies with the potential to improve the quality of life to patients and ...See details»
Press Release - ir.astriatx.com
Oct 30, 2024 Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by allergic and immunologic diseases.See details»
IR CONTACT - Astria Therapeutics
E-mail: [email protected]. Print Page; RSS Feeds; Email Alerts; For Patients (HAE) ALPHA-STAR Trial. Patient Stories. Newsletters. Resources. For Patients (Atopic Dermatitis) …See details»
ASTRIA THERAPEUTICS, INC. Boston, MA 02109 NOTICE OF 2024 …
Www.sec.gov and our website at www.astriatx.com. 1. IMPORTANT INFORMATION ABOUT THE ANNUAL MEETING AND VOTING Purpose of the Annual Meeting At the Annual Meeting, our …See details»
Astria Therapeutics - Overview, News & Similar companies
Nov 13, 2023 Astria Therapeutics contact info: Phone number: (617) 349-1971 Website: www.astriatx.com What does Astria Therapeutics do? Astria Therapeutics is a …See details»
Mission & Values - Astria TX
Our mission is to bring hope with life-changing therapies to patients and families affected by allergic and immunologic diseases. Our vision is a world where science, passion, and compassion create better todays and more tomorrows. …See details»
Astria Therapeutics, Inc. (ATXS) Company Profile & Overview
Jun 25, 2015 Ticker Symbol: ATXS: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001454789: CUSIP Number: 04635X102: ISIN …See details»
Contact Us - Astria TX
Address: 22 Boston Wharf Road 10th Floor Boston, MA 02210. P: 617-349-1971 F: 617-273-2637See details»
Astria Therapeutics Reports Third Quarter 2021 Financial Results …
Sep 30, 2021 Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and …See details»
AstriaTx (@astriatx) • Instagram photos and videos
89 Followers, 22 Following, 208 Posts - AstriaTx (@astriatx) on Instagram: "Our name, the Greek word for star, says it all. At Astria, patients are the stars that guide us in the development of life …See details»
SECURITIES AND EXCHANGE COMMISSION - ir.astriatx.com
Us04635x1028_102424.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: )See details»
Resources - Astria TX
Learn more about HAE here: Our Science/About HAE Discover how we are developing navenibart (STAR-0215) as a preventative therapy for HAE with dosing once every 3 and 6 months: Our …See details»
Astria Therapeutics, Inc. (ATXS) - Stock Analysis
2 days ago Website https://www.astriatx.com. Full Company Profile. Financial Performance. Financial Statements. Analyst Forecast. According to 5 analysts, the average rating for ATXS …See details»
Press Release - Astria Therapeutics
Oct 11, 2023 Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by allergic and immunological diseases.See details»
AD Patient Resources - Astria TX
You may at any time withdraw your consent to receive our electronic communications, in which case we will also delete your personal data connected to receiving our electronic …See details»
Astria Therapeutics to Present at Upcoming European Academy of ...
Sep 19, 2024 BOSTON--(BUSINESS WIRE)--Sep. 19, 2024-- Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies …See details»